AA
Ascentage Pharma Group International
AAPG · NASDAQ
$15.06 -2.02% (-$0.31)
1M -9.87%
Market Cap ¥2.34B
P/E Ratio -
Div. Yield -
ROE 171.96%
Piotroski F-Score Weak
2/9Valuation
68 /100
Cheap P/B 1.77x
P/S 4.19x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 48.02%
Rev. growth 38.61%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 211.14%
Gross margin 76.41%
FCF margin 215.17%
Quality
2 /100
Poor ROA 30.48%
ROIC 33.45%
Asset turnover 0.14x
Debt
37 /100
Moderate Int. coverage -22.42x
Debt/Equity 1.49x
Current ratio 1.79x
Stability
26 /100
Unstable EPS volatility 122.93%
Beta 0.66x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AAPG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Nadcházející události
31 BŘE
Earnings
Upcoming earnings report